Navigation Links
Allergy Shots Are Effective Treatment for Symptoms
Date:1/26/2008

Immunotherapy works for allergic asthma, rhinitis, conjunctivitis or insect bites

SATURDAY, Jan. 26 (HealthDay News) -- If you have allergic asthma, rhinitis, conjunctivitis or stinging insect allergies, you may be a good candidate for allergy shots, also known as immunotherapy.

That's the recommendation of the American Academy of Allergy, Asthma & Immunology.

"Immunotherapy is a form of treatment that aims to decrease sensitivity to substances called allergens," Dr. Linda Cox, chair of the AAAAI's Immunotherapy and Allergy Diagnostics Committee, said in a prepared statement.

"Allergens, like pollen, mold or animal dander, are substances that trigger allergy symptoms when an allergic person is exposed to them. Patients who receive immunotherapy are injected with increasing amounts of an allergen until the target therapeutic dose is reached, in an effort to build resistance to specific allergens," Cox explained.

She said relief of allergy symptoms can last long after completion of treatment and that immunotherapy helps prevent the development of new allergies and may prevent the progression of allergic rhinitis to asthma.

Immunotherapy involves injections of gradually increasing doses of a particular allergen. Your body responds by developing immunity or tolerance to the allergen, resulting in decreased symptoms when you're exposed to the allergen.

While immunotherapy is recommended for people with allergic asthma, rhinitis, conjunctivitis and stinging insect allergies, it's not recommended for those with food allergies, the AAAAI said. The best option for people with food allergies is to avoid foods that pose a danger.

The AAAAI says people should see a doctor about immunotherapy if they:

  • Have a clear relationship between asthma, rhinitis, conjunctivitis, and exposure to an allergen,
  • Have a poor response to allergy medication or avoidance measures
    '/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
2. A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms
3. Protein a possible key to allergy and asthma control
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
5. Parents Smoking Boosts Childs Allergy Risk
6. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
7. Allergy Foundation Thinks Globally, Gifts Locally
8. Tis the Season For Allergy, Asthma
9. FDA Approves the Allergy Treatment Zyrtec(R) for Use Without a Prescription
10. Austin Named the New Fall Allergy Capital
11. Breast-Feeding Cuts Food Allergy Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis 2Discover Health Through Awareness 2Discover Health Through Awareness 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 1HCA Names Joe Sowell Senior Vice President 26amp 3B Chief Development Officer 61620 2Niusule Expands Geographic Footprint in China 14900 1Niusule Expands Geographic Footprint in China 14900 2Niusule Expands Geographic Footprint in China 14900 3Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 1Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 2Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 3Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 4Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 5Peregrine Pharmaceuticals Presents Promising Antiviral Data at 2009 Chemical and Biological Defense Science 26amp 3B Technology Conference 14897 6